Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

L.A. McKeown

May 22, 2025

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

News Conference News EuroPCR 2023

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Michael O'Riordan

May 16, 2023

News Opinion Editor's Corner EuroPCR 2022

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

Shelley Wood

May 12, 2022

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Conference News EuroPCR 2017

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Shelley Wood

June 02, 2017

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve The ARTE Randomized Clinical Trial

Presentation EuroPCR 2017

The ARTE Randomized Clinical Trial

Presenter: Josep Rodés-Cabau

May 17, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

News Conference News EuroPCR 2016

WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients

Caitlin E. Cox

May 17, 2016

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

Advertisement

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

First report of an IDE pivotal study of a dedicated splitting device during TAVR

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

The ARTE Randomized Clinical Trial

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content